Evaluation of Neutrophil-Related Parameters by Hematology Analyzer for Detection of Myelodysplastic Syndromes.
Standard blood counts already contain hidden patterns for detecting pre-cancer in bone marrow, requiring no extra lab tests.
Using parameters already reported by modern automated hematology analyzers (such as neutrophil granularity, nuclear lobularity index, and activation markers), this study evaluated their ability to distinguish MDS patients from normal controls and other cytopenias. The approach leverages existing laboratory infrastructure for low-cost MDS detection, directly addressing the CBC-ML topic of using routine blood count parameters for hematologic disease diagnosis.
What the study was
- Study design
- diagnostic_cohort
- Population
- MDS patients and controls with hematology analyzer data
- Category
- Diagnostics
- Maturity
- Exploratory
- Journal
- Clin Lab
Why it surfaced
Directly addresses CBC-based ML hematology diagnostic topic; uses routine hematology analyzer parameters (no additional testing) for MDS detection—clinically actionable and scalable to any laboratory with modern CBC analyzers; MDS is underdiagnosed due to nonspecific symptoms.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.